Abuse deterrent (or deterrence) testing is an important component of addressing the serious and growing public health problem of abuse and misuse of prescription products. We provide independent, non-biased testing conducted by experts especially for abuse deterrent formulations using real-world methodologies. Our three main areas of focus are:
Pseudoephedrine Formulations
- API extractability
- Multiple methods
 
 - Conversion to methamphetamine
- HI/P
 - Lithium in ammonia
 - “One-pot”
 
 

Opioid Formulations
- Evaluation of intact and adulterated formulations
- Dissolution testing
 - Tablet hardness
 - Crushability
 - Syringeability/viscosity
 - Vaporization
 - Particle size analysis
 - Extractability
 
 

Other Controlled Substances Formulations
- Formulation-specific evaluations
 

For more information about some of our capabilities, please see our recent announcement under the Publications section. We have significant experience in evaluating abuse deterrent formulations using real-world methodologies. We also offer all the techniques necessary to fully assess a new formulation’s performance and can act as an independent test source for new products. In addition to dissolution testing, we offer tablet hardness, crushablility, syringeability/viscosity, vaporization, particle size analysis, and extractability. We can also assist with formulation design.
To learn more, please contact us at info@improvedpharma.com.
